Culturally adapted mobile cognitive behavioral therapy for chronic pain in adolescent survivors of childhood cancer
Official title: Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial
Run by St. Jude Children's Research Hospital · NCT07160621 · Data updated 2026-11-12
This trial tests whether a culturally adapted mobile cognitive behavioral therapy app can help adolescent survivors of childhood cancer reduce chronic pain and improve daily life, with a caregiver taking part too.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 10 Years to 17 Years |
| Sex | All |
| Enrollment | 116 (estimated) |
| Sponsor | St. Jude Children's Research Hospital Academic / other |
| Locations | 1 site (Memphis, Tennessee) |
| Status | Recruiting |
| Started | September 5, 2025 |
| Main results expected | January 2028 |
| Study ends | January 2029 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT07160621 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 10–17-year-old survivors of childhood cancer who are at least one year off treatment, have pain for three months or longer that interferes with daily life, and have a consenting caregiver aged 18 or older.
✕Probably not a fit
Patients with serious psychiatric illness, current substance abuse, significant cognitive impairment or developmental delay, or caregivers not fluent in English or Spanish are unlikely to benefit from or be eligible for this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized study will enroll 228 participants (114 adolescent survivors aged 10–17 plus 114 caregivers) across four U.S. pediatric centers and randomize adolescents to use an adapted mobile CBT app or to receive standard pain education for six weeks. The app is designed for at-home use with a recommended 2–3 sessions per week, while outcomes are measured at baseline, post-treatment, and three-month follow-up. Primary outcomes include pain intensity and functional disability, and analyses will consider the influence of social determinants of health. Participants are screened for eligibility including pain duration (≥3 months), being ≥1 year off cancer treatment, and exclusion of serious psychiatric or cognitive conditions.
Why it matters
Potential benefit: If successful, the app could reduce chronic pain and improve daily functioning for adolescent cancer survivors while offering a convenient, culturally tailored option families can use at home.
How similar studies have gone: Mobile CBT programs for pediatric chronic pain have shown promise in prior work and a feasibility ADAPTED study informed this trial, but large randomized trials specifically in adolescent cancer survivors remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Adolescent Participants
* 10-17-year-old survivors of childhood cancer or those who received cancer directed therapies (e.g., Langerhan's Histiocytosis)
* At least one-year post treatment completion
* Pain present for 3 months or longer
* Pain interfering with at least one area of daily functioning
* Parent/Caregiver Participants
* ≥ 18 years of age
* Legally authorized to provide informed consent for the adolescent participant
Exclusion Criteria:
* Adolescent Participants
* Serious comorbid psychiatric condition
* Current substance abuse as determined by the Substance Use Screening Questionnaire
* History of development delay or significant cognitive impairment
* Note: A participant who completed the feasibility study (ADAPTED) cannot participate in the subsequent clinical trial (ADAPTED2)
* Parent/Caregiver Participants
* Not fluent in English or Spanish
* Unable to provide consent for own participation or for the participation of the adolescent participant
Where it's running
-
St. Jude Children's Research Hospital
Memphis, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Tara Brinkman, PhD — St. Jude Children's Research Hospital
- Study coordinator: Tara Brinkman, PhD
- Email: referralinfo@stjude.org
- Phone: 888-226-4343
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.